Could It Be Lupus? Symptoms, Blood Tests and When to Seek Specialist Advice
Lupus (systemic lupus erythematosus, or SLE) is an autoimmune condition where the immune system becomes overactive and can cause inflammation in multiple organs. It can affect the skin and joints, but also the kidneys, lung lining, heart lining, blood cells and (more rarely) the nervous system.
A key point: lupus is not “one symptom”. It is a pattern of symptoms and clinical findings that fit with specific immune processes. This is why diagnosis usually relies on a structured clinical assessment plus targeted investigations, rather than a single blood test.
Who tends to get lupus?
Lupus can affect anyone, but it is most common in women, particularly between the ages of 15 and 45. It is also seen more frequently — and can be more severe — in certain ethnic groups, including people of Black African or Caribbean heritage and Asian backgrounds. These differences are thought to reflect a combination of genetic susceptibility and wider health determinants. Importantly, lupus can still occur in men, in older adults, and in people of any ethnicity, so diagnosis is based on clinical features rather than demographics alone.
What symptoms are more suggestive of lupus?
Many symptoms can occur in lots of conditions, but some are particularly relevant to lupus and connective tissue disease.
Skin and mucosal features
Photosensitivity (rash triggered or worsened by sunlight/UV exposure)
Facial rash in some patients (not everyone; and it’s not always classic)
Mouth or nasal ulcers, often recurrent
Hair thinning or shedding during flares (inflammatory rather than “male-pattern” hair loss)
Circulation and small vessel symptoms
Raynaud’s (fingers/toes turning white/blue/red with cold or stress)
Chilblain-like lesions can occur in some autoimmune settings
(See: Raynaud’s and Chilblains.)
Joints (very common in lupus)
Aching and stiffness, typically hands/wrists
Inflammatory-type stiffness (often morning worse, improving with movement)
Swelling can occur, but in lupus it may be more intermittent than in RA
Chest symptoms (serositis)
Sharp chest pain worse with breathing can reflect pleuritis (lung lining inflammation)
Central chest pain worse lying flat can reflect pericarditis (heart lining inflammation)
Kidney involvement (important—and can be silent)
Lupus can inflame the filtering units of the kidney (glomeruli). Some patients have no obvious symptoms early on, which is why urine testing matters. Possible clues:
frothy urine
swelling around ankles/eyes
rising blood pressure
But sometimes the only clues are protein/blood in urine on testing.
Blood and clotting features
low white cells, low platelets or anaemia on blood tests
history of thrombosis or recurrent pregnancy loss in some patients (suggesting antiphospholipid syndrome—tested when clinically relevant)
Neurological features
Neurological symptoms can occur in lupus, but they also have many other causes. Symptoms that warrant emergency assessment include:
new weakness, numbness, speech disturbance
seizures
marked confusion or severe cognitive change
significant visual symptoms
The approach is always to assess carefully and investigate when appropriate, rather than assuming symptoms are lupus-related without supporting evidence.
Why lupus happens
Lupus is driven by a combination of:
genetic susceptibility
immune dysregulation
environmental triggers (which can include infections, UV light, and hormonal influences)
Two key immune concepts help explain lupus:
1) Autoantibodies and immune complexes
Many patients produce autoantibodies (antibodies that bind to the body’s own components—often nuclear material). These can form immune complexes (clusters of antibody + antigen) that circulate and deposit in tissues, triggering inflammation.
This is one reason lupus can affect multiple organs and why symptoms can flare.
2) Complement consumption
Complement proteins (especially C3 and C4) help regulate immune complex clearance. During active lupus—particularly when immune complexes are prominent—complement levels can fall (“consumption”). Low complement can therefore be a clue to disease activity in the right context.
3) Interferon signalling
A lot of modern lupus research focuses on type I interferon pathways, which amplify immune activation. This helps explain why some lupus symptoms behave like “immune overdrive” and why newer treatments increasingly target specific immune signalling pathways rather than blanket immune suppression.
Could it be something else?
Yes—and this is exactly why seeing a specialist and having a comprehensive clinical assessment is important.
Persistent, symmetrical inflammatory hand swelling with prolonged morning stiffness may fit rheumatoid arthritis more closely
(See: Rheumatoid Arthritis – Symptoms, Diagnosis and Treatment.)
Psoriasis, nail pitting, tendon pain, or back pain may suggest psoriatic arthritis or spondyloarthritis
(See: Psoriatic Arthritis and Axial Spondyloarthritis: Symptoms, Diagnosis and Treatment.)
Widespread pain, poor sleep and heightened sensitivity may suggest fibromyalgia, which can coexist with autoimmune disease but needs different management
(See: Fibromyalgia: Making Sense of Widespread Pain and Fatigue.)
Blood tests: what they do (and what they do not) prove
ANA: useful screening marker, not a diagnosis
Most lupus patients have a positive ANA, but many people without lupus also have a positive ANA. So ANA supports a diagnosis only when the clinical picture is consistent.
(See: ANA Positive: What It Means (and What It Doesn’t) and Blood Tests in Rheumatology: What Do CRP, ESR, ANA and Rheumatoid Factor Really Mean?.)
More specific lupus-related tests (ordered when clinically appropriate)
If lupus is suspected, targeted testing may include:
anti–double stranded DNA (anti-dsDNA) (more specific; can correlate with activity in some patients)
ENA antibodies (e.g., anti-Ro/La, anti-Sm, anti-RNP) depending on phenotype
Complement (C3/C4)
Full blood count
Kidney function
Urinalysis and urine protein assessment (central in suspected lupus)
The sequencing matters:
clinical assessment → targeted tests → interpretation in context
This avoids false positives and unnecessary anxiety.
(See: When Tests Create More Questions Than Answers.)
Tests beyond bloods and urine: what else is sometimes needed?
Not everyone with suspected lupus needs additional tests beyond bloods and urine. However, if symptoms suggest specific organ involvement, further investigations may be helpful. These are chosen based on the clinical picture, for example:
Heart and chest assessment
ECG if chest pain or palpitations are present
Chest X-ray if there are respiratory symptoms
Echocardiogram (heart ultrasound) if pericarditis is suspected or there is breathlessness
Sometimes CT imaging if there are concerns about lung involvement or clots
Joint and tendon assessment
Ultrasound can help confirm synovitis (inflammation) when swelling is subtle
X-rays may be used to assess for alternative diagnoses or baseline joint assessment
Kidney assessment (when needed)
Urine and blood tests are first-line, but if there is significant concern about kidney involvement, patients may be referred for specialist renal assessment and occasionally a kidney biopsy.
Nervous system assessment (selected cases)
If neurological symptoms are prominent, investigation may include imaging (often MRI), nerve conduction studies and EEG depending on symptoms, and when clinically appropriate.
When to seek specialist advice
Consider specialist assessment if you have:
features suggestive of connective tissue disease (photosensitivity, recurrent ulcers, Raynaud’s, characteristic rash)
inflammatory joint symptoms (persistent swelling or prolonged morning stiffness)
chest pain suggestive of pleuritis/pericarditis
abnormal urine tests (blood/protein), new swelling, or high blood pressure
unexplained low blood counts
multi-system symptoms that do not fit a simpler explanation
Modern treatment: what management typically involves
Treatment is individualised based on organ involvement and activity. Many patients do well with a structured, stepwise plan.
Core long-term treatment
Hydroxychloroquine is widely used because it can reduce flares and is generally well tolerated (with appropriate monitoring)
Managing flares and organ-threatening disease
Steroids may be used for flares, ideally at the lowest dose for the shortest time
(See: Steroids in Rheumatic Disease.)
Steroid-sparing immune therapies (depending on the organ system)
drugs such as azathioprine, mycophenolate, methotrexate and others
(See: DMARDs in Rheumatology.)
Biologic and targeted therapies
Lupus uses different biologics from inflammatory arthritis, but the principle is similar: more targeted immune modulation for selected patients.
Lupus and pregnancy: planning makes a major difference
Many women with lupus have successful pregnancies. The most important principles are:
aim for stable disease control before conception (often around 6 months stability is a useful guide)
review medications early (some are safe, others must be stopped well in advance)
monitor blood pressure, kidney function and urine carefully
consider antiphospholipid antibodies when there is relevant history
Broadly:
often continued: hydroxychloroquine; some steroids; and certain immunosuppressants such as azathioprine when needed
avoided in pregnancy: methotrexate and mycophenolate (requires advance planning)
Emerging treatments
Treatment continues to evolve. Beyond established immunomodulators and biologics, there is increasing interest in highly targeted approaches for severe refractory disease. CAR-T cell therapy is being explored in specialist centres for selected autoimmune diseases and reflects the direction of travel toward immune “reprogramming”. It is not routine care for most lupus patients, but it is an important area of development.
Final thoughts
Lupus is a condition where the immune system can drive inflammation across different organs, which is why diagnosis relies on recognising the clinical pattern and using targeted investigations to confirm (or exclude) connective tissue disease.
Many symptoms that occur in lupus — such as joint pains, rashes and fatigue — can also occur in other conditions, so it is rarely appropriate to make conclusions from a single blood test in isolation.
Outcomes for people living with lupus have improved significantly over recent decades, driven by earlier recognition, better monitoring (particularly of kidney and cardiovascular risk), and more effective long-term treatments.
The clinical priority is to identify those with features of active inflammatory or organ involvement early, so that monitoring and treatment can be started promptly and tailored to the individual.
Trusted patient resources
Arthritis UK – Lupus (SLE): clear explanations of symptoms, causes and treatment.
https://www.arthritis-uk.org/information-and-support/understanding-arthritis/conditions/lupus-sle/
LUPUS UK – What is lupus?: practical patient information and FAQs.
https://lupusuk.org.uk/what-is-lupus/
NHS – Lupus (SLE) overview: symptoms, diagnosis and treatment basics.
Please note, these posts are for general information only and do not constitute medical advice. Dr Singh would encourage you to speak to your healthcare professional to be assessed and managed for your specific symptoms.